Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 26 - Embracing Change and Overcoming Resistance With Adama Ibrahim
Trends from the Trenches
33 minutes
1 year ago
Episode: 26 - Embracing Change and Overcoming Resistance With Adama Ibrahim
Change can be scary, but it can also bring new opportunities and lead to growth and innovation. In this episode of Trends from the Trenches, host Stan Gloss from BioTeam and Adama Ibrahim, VP of Digital Strategy & Change Management at Novo Nordisk, delve into a conversation about humanity’s natural resistance to change, why it is important to overcome that resistance, and how change is the key to making progress. Ibrahim also shares how Novo Nordisk is supporting research organizations th...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
